|
1
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagini S: Carcinoma of the stomach: A
review of epidemiology, pathogenesis, molecular genetics and
chemoprevention. World J Gastrointest Oncol. 4:156–169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zang ZJ, Cutcutache I, Poon SL, Zhang SL,
McPherson JR, Tao J, Rajasegaran V, Heng HL, Deng N, Gan A, et al:
Exome sequencing of gastric adenocarcinoma identifies recurrent
somatic mutations in cell adhesion and chromatin remodeling genes.
Nat Genet. 44:570–574. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Finkel T, Deng CX and Mostoslavsky R:
Recent progress in the biology and physiology of sirtuins. Nature.
460:587–591. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuan H, Su L and Chen WY: The emerging and
diverse roles of sirtuins in cancer: A clinical perspective. Onco
Targets Ther. 6:1399–1416. 2013.PubMed/NCBI
|
|
6
|
Haigis MC, Mostoslavsky R, Haigis KM,
Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos
GD, Karow M, Blander G, et al: SIRT4 inhibits glutamate
dehydrogenase and opposes the effects of calorie restriction in
pancreatic beta cells. Cell. 126:941–954. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jeong SM, Xiao C, Finley LW, Lahusen T,
Souza AL, Pierce K, Li YH, Wang X, Laurent G, German NJ, et al:
SIRT4 has tumor-suppressive activity and regulates the cellular
metabolic response to DNA damage by inhibiting mitochondrial
glutamine metabolism. Cancer Cell. 23:450–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Csibi A, Fendt SM, Li C, Poulogiannis G,
Choo AY, Chapski DJ, Jeong SM, Dempsey JM, Parkhitko A, Morrison T,
et al: The mTORC1 pathway stimulates glutamine metabolism and cell
proliferation by repressing SIRT4. Cell. 153:840–854. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miyo M, Yamamoto H, Konno M, Colvin H,
Nishida N, Koseki J, Kawamoto K, Ogawa H, Hamabe A, Uemura M, et
al: Tumour-suppressive function of SIRT4 in human colorectal
cancer. Br J Cancer. 113:492–499. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang G, Cheng J, Yu F, Liu X, Yuan C, Liu
C, Chen X and Peng Z: Clinical and therapeutic significance of
sirtuin-4 expression in colorectal cancer. Oncol Rep. 35:2801–2810.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakahara Y, Yamasaki M, Sawada G, Miyazaki
Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S,
Mimori K, et al: Downregulation of SIRT4 expression is associated
with poor prognosis in esophageal squamous cell carcinoma.
Oncology. 90:347–355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang G, Cui F, Yu F, Lu H, Zhang M, Tang
H and Peng Z: Sirtuin-4 (SIRT4) is downregulated and associated
with some clinicopathological features in gastric adenocarcinoma.
Biomed Pharmacother. 72:135–139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roth M and Chen WY: Sorting out functions
of sirtuins in cancer. Oncogene. 33:1609–1620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH,
Park HS, Lee H, Chung MJ, Kang MJ, Lee DG, et al: Expression of
DBC1 and SIRT1 is associated with poor prognosis of gastric
carcinoma. Clin Cancer Res. 15:4453–4459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stünkel W, Peh BK, Tan YC, Nayagam VM,
Wang X, Salto-Tellez M, Ni B, Entzeroth M and Wood J: Function of
the SIRT1 protein deacetylase in cancer. Biotechnol J. 2:1360–1368.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huffman DM, Grizzle WE, Bamman MM, Kim JS,
Eltoum IA, Elgavish A and Nagy TR: SIRT1 is significantly elevated
in mouse and human prostate cancer. Cancer Res. 67:6612–6618. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hida Y, Kubo Y, Murao K and Arase S:
Strong expression of a longevity-related protein, SIRT1, in Bowen's
disease. Arch Dermatol Res. 299:103–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang RH, Sengupta K, Li C, Kim HS, Cao L,
Xiao C, Kim S, Xu X, Zheng Y, Chilton B, et al: Impaired DNA damage
response, genome instability, and tumorigenesis in SIRT1 mutant
mice. Cancer Cell. 14:312–323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Firestein R, Blander G, Michan S,
Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S,
de Cabo R, Fuchs C, et al: The SIRT1 deacetylase suppresses
intestinal tumorigenesis and colon cancer growth. PLoS One.
3:e20202008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim HS, Vassilopoulos A, Wang RH, Lahusen
T, Xiao Z, Xu X, Li C, Veenstra TD, Li B, Yu H, et al: SIRT2
maintains genome integrity and suppresses tumorigenesis through
regulating APC/C activity. Cancer Cell. 20:487–499. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hiratsuka M, Inoue T, Toda T, Kimura N,
Shirayoshi Y, Kamitani H, Watanabe T, Ohama E, Tahimic CG, Kurimasa
A and Oshimura M: Proteomics-based identification of differentially
expressed genes in human gliomas: Down-regulation of SIRT2 gene.
Biochem Biophys Res Commun. 309:558–566. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ming M, Qiang L, Zhao B and He YY:
Mammalian SIRT2 inhibits keratin 19 expression and is a tumor
suppressor in skin. Exp Dermatol. 23:207–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dan L, Klimenkova O, Klimiankou M, Klusman
JH, van den Heuvel-Eibrink MM, Reinhardt D, Welte K and Skokowa J:
The role of sirtuin 2 activation by nicotinamide
phosphoribosyltransferase in the aberrant proliferation and
survival of myeloid leukemia cells. Haematologica. 97:551–559.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hou H, Chen W, Zhao L, Zuo Q, Zhang G,
Zhang X, Wang H, Gong H, Li X, Wang M, et al: Cortactin is
associated with tumour progression and poor prognosis in prostate
cancer and SIRT2 other than HADC6 may work as facilitator in situ.
J Clin Pathol. 65:1088–1096. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong SM, Lee A, Lee J and Haigis MC:
SIRT4 suppresses tumor formation in genetic models of Myc-induced B
cell lymphoma. J Biol Chem. 289:4135–4144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hall M and Peters G: Genetic alterations
of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human
cancer. Adv Cancer Res. 68:67–108. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chambard JC, Lefloch R, Pouyssegur J and
Lenormand P: ERK implication in cell cycle regulation. Biochim
Biophys Acta. 1773:1299–1310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohtsubo M, Theodoras AM, Schumacher J,
Roberts JM and Pagano M: Human cyclin E, a nuclear protein
essential for the G1-to-S phase transition. Mol Cell Biol.
15:2612–2624. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ohtsubo M and Roberts JM: Cyclin-dependent
regulation of G1 in mammalian fibroblasts. Science. 259:1908–1912.
1993. View Article : Google Scholar : PubMed/NCBI
|
